Evidence map›Paper›PMID 31863590›Full record

ArticleNucleic acids research2020

The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis.

Tuan M Nguyen, Elena B Kabotyanski, Lucas C Reineke, Jiaofang Shao, Feng Xiong, Joo-Hyung Lee, Julien Dubrulle, Hannah Johnson, Fabio Stossi, Phoebe S Tsoi and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 63 citations in OpenAlex.

  1. A B1 SINE element within the mouseScience advances · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. TDP-43: unveiling the hidden key to cellular fate decisions.Cell communication and signaling : CCS · 2025
    Review
  11. Regulation of the lncRNANAR molecular medicine · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 1 country.

Tuan M NguyenCancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Elena B KabotyanskiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Lucas C ReinekeDepartment of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.
Jiaofang ShaoDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.
Feng XiongDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.
Joo-Hyung LeeDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.
Julien DubrulleIntegrated Microscopy Core, Baylor College of Medicine, Houston, TX 77030, USA.
Hannah JohnsonIntegrated Microscopy Core, Baylor College of Medicine, Houston, TX 77030, USA.
Fabio StossiIntegrated Microscopy Core, Baylor College of Medicine, Houston, TX 77030, USA.
Phoebe S TsoiDepartment of Pharmacology and Chemical Biology, Houston, TX 77030, USA.
Kyoung-Jae ChoiDepartment of Pharmacology and Chemical Biology, Houston, TX 77030, USA.
Alexander G EllisMichael E. DeBakey High School for Health Professions, Houston, TX 77030, USA.
Na ZhaoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Jin CaoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Oluwatoyosi AdewunmiCancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Josephine C FerreonDepartment of Pharmacology and Chemical Biology, Houston, TX 77030, USA.
Allan Chris M FerreonDepartment of Pharmacology and Chemical Biology, Houston, TX 77030, USA.
Joel R NeilsonDepartment of Molecular Physiology and Biophysics, Houston, TX 77030, USA.
Michael A ManciniIntegrated Microscopy Core, Baylor College of Medicine, Houston, TX 77030, USA.
Xi ChenDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Jongchan KimDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Li MaDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Wenbo LiDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX 77030, USA.
Jeffrey M RosenDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Baylor College of Medicine · USThe University of Texas Health Science Center at Houston · USBeth Israel Deaconess Medical Center · USThe University of Texas MD Anderson Cancer Center · USMichael E. DeBakey VA Medical Center · USRadiation Biophysics Laboratory · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
MALAT1 lncRNA as a Therapeutic Target in Triple Negative Breast CancerR01CA016303 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ROSEN, JEFFREY MARK · 1985 to 2022
$8.1M
Structure and Functionof Nanog in Stem Cell PluripotencyR01GM122763 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Josephine Chu Ferreon · 2018 to 2026
$3.4M
Regulation of metastasis and epithelial-mesenchymal transition by microRNAsR01CA166051 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MA, LI · 2012 to 2023
$3.4M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
Translational control of EMT by the CELF1 RNA Binding ProteinR01CA190467 · NCI · BAYLOR COLLEGE OF MEDICINE · PI NEILSON, JOEL R · 2015 to 2021
$1.9M
Condensin-mediated enhancer and chromatin architectural control of breast cancer gene transcriptionK22CA204468 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, WENBO · 2017 to 2019
$486k
Pharmacologic inhibition of ribonucleoprotein droplet maturationR21NS109678 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI FERREON, ALLAN CHRIS · 2019 to 2019
$440k
Mechanism of Pathologic hnRNP Droplet MaturationR21NS107792 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI FERREON, ALLAN CHRIS · 2019 to 2019
$439k
Optogenetic Engineering of 3D Chromatin ArchitectureR21GM132778 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LI, WENBO · 2019 to 2020
$434k
NCI NIH HHS K22 CA204468NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA016303NCI NIH HHS R01 CA166051NCI NIH HHS R01 CA190467NIDDK NIH HHS P30 DK056338NIGMS NIH HHS R01 GM122763NIGMS NIH HHS R21 GM132778NIGMS NIH HHS T32 GM088129NINDS NIH HHS F31 NS103380NINDS NIH HHS R21 NS107792NINDS NIH HHS R21 NS109678
6 · The paper itself

Abstract

Transposable elements (TEs) comprise a large proportion of long non-coding RNAs (lncRNAs). Here, we employed CRISPR to delete a short interspersed nuclear element (SINE) in Malat1, a cancer-associated lncRNA, to investigate its significance in cellular physiology. We show that Malat1 with a SINE deletion forms diffuse nuclear speckles and is frequently translocated to the cytoplasm. SINE-deleted cells exhibit an activated unfolded protein response and PKR and markedly increased DNA damage and apoptosis caused by dysregulation of TDP-43 localization and formation of cytotoxic inclusions. TDP-43 binds stronger to Malat1 without the SINE and is likely 'hijacked' by cytoplasmic Malat1 to the cytoplasm, resulting in the depletion of nuclear TDP-43 and redistribution of TDP-43 binding to repetitive element transcripts and mRNAs encoding mitotic and nuclear-cytoplasmic regulators. The SINE promotes Malat1 nuclear retention by facilitating Malat1 binding to HNRNPK, a protein that drives RNA nuclear retention, potentially through direct interactions of the SINE with KHDRBS1 and TRA2A, which bind to HNRNPK. Losing these RNA-protein interactions due to the SINE deletion likely creates more available TDP-43 binding sites on Malat1 and subsequent TDP-43 aggregation. These results highlight the significance of lncRNA TEs in TDP-43 proteostasis with potential implications in both cancer and neurodegenerative diseases.

Indexed as

ApoptosisCell LineCytoplasmDNA-Binding ProteinsDNA DamageeIF-2 KinaseEndoplasmic Reticulum StressEnzyme ActivationGene DosageHeterogeneous-Nuclear Ribonucleoprotein KHumansMitosisModels, BiologicalProtein TransportProteostasisRNA, Long NoncodingDNA-Binding ProteinseIF-2 KinaseHeterogeneous-Nuclear Ribonucleoprotein KMALAT1 long non-coding RNA, humanRNA, Long NoncodingRNA, MessengerTARDBP protein, human

Identifiers

PMID31863590
PMCPMC7049706
OpenAlexW2912245607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.